Guide-catheter extension system facilitated multiple bioresorbable vascular scaffolds (ABSORB®) delivery in a very long and resistant coronary artery lesion
- PMID: 24054502
- DOI: 10.1016/j.carrev.2013.08.004
Guide-catheter extension system facilitated multiple bioresorbable vascular scaffolds (ABSORB®) delivery in a very long and resistant coronary artery lesion
Abstract
We report the case of a 77-year-old male patient who was admitted to our institution for non-ST segment elevation myocardial infarction. Coronary angiography showed a sub-occlusive lesion of the distal left anterior descending artery (LAD) in the context of a diffuse atherosclerotic disease involving a very long segment of the vessel (about 80mm in length by visual estimation). Pre-dilatation was performed in the mid calcified segment of the LAD with a non-compliant balloon inducing vessel dissection. An everolimus-eluting bioresorbable vascular scaffold (EEBVS) was then advanced in the LAD but the first delivery attempt at the distal site failed because of friction between the EEBVS struts and the calcified vessel wall. In order to facilitate EEBVS delivery, a 5Fr catheter system (Heart Rail II, Terumo, Tokyo, Japan) was advanced in the mid LAD within a standard 6Fr guiding catheter facilitating a non-traumatic deep intubation up to the mid LAD. This strategy increased back-up support facilitating the delivery, beyond the site of resistance, of four EEBVS implanted in overlap. This case demonstrated the successful use of a guide catheter extension system to deliver multiple EEBVS in a patient with a long, calcified LAD lesion.
Keywords: Coronary angioplasty; Stenosis; Stent.
© 2014.
Similar articles
-
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016. JACC Cardiovasc Interv. 2014. PMID: 25523532 Clinical Trial.
-
Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.JACC Cardiovasc Interv. 2012 Jun;5(6):656-65. doi: 10.1016/j.jcin.2012.02.017. JACC Cardiovasc Interv. 2012. PMID: 22721662 Clinical Trial.
-
The rotational atherectomy with a guide extension catheter for calcified and tortuous lesions in left anterior descending artery: a case report.BMC Cardiovasc Disord. 2021 Jul 30;21(1):360. doi: 10.1186/s12872-021-02167-3. BMC Cardiovasc Disord. 2021. PMID: 34330212 Free PMC article.
-
Bioresorbable Scaffolds for Coronary Artery Disease.Curr Cardiol Rep. 2017 Jan;19(1):5. doi: 10.1007/s11886-017-0812-7. Curr Cardiol Rep. 2017. PMID: 28108898 Review.
-
Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.Catheter Cardiovasc Interv. 2015 Oct;86(4):686-91. doi: 10.1002/ccd.26055. Epub 2015 Jun 29. Catheter Cardiovasc Interv. 2015. PMID: 26122768 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical